Gilead in talks to expand global supply of Covid-19 drug remdesivir

Gilead said it was working to build a consortium of manufacturing partners to help maximise global supply of the drug. - Reuters

BENGALURU (Rueters): Gilead Sciences Inc said on Tuesday (May 5) it was in discussions with chemical and drug manufacturers to produce its experimental Covid-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.

The drugmaker did not disclose details about the companies.